Compare iShares MSCI Germany (DAX) (EWG) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Pfizer Inc — how do they compare? iShares MSCI Germany (DAX) trades at $41.19, while Pfizer Inc trades at $25.08 (market cap $141.46B). The key difference: Pfizer Inc pays a 6.93% dividend while iShares MSCI Germany (DAX) pays none, and iShares MSCI Germany (DAX) is trading nearer its 52-week high, Pfizer Inc nearer its low. Which is the better fit depends on your goals.
| EWG | PFE | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $44.56 | $28.56 |
52-Week Low | $38.08 | $23.29 |
Market Cap | — | $141.46B |
Volume | — | 29,869,932 |
Enterprise Value | — | $192.12B |
Dividend Yield | — | 6.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG is trading at $41.19, down 0.48% on the day with a neutral technical signal. The stock shows mixed technical indicators with bearish moving averages but oversold RSI conditions. Recent German economic developments, including a €13.3 billion energy relief package and healthcare reforms, create a complex backdrop for this US-listed German-focused ETF.
The outlook remains balanced with European monetary policy uncertainty and energy market volatility presenting both opportunities and risks. German fiscal support measures could provide stability, while ECB rate decisions and Middle East tensions may drive near-term volatility in European markets.
Pfizer (PFE) trades at $24.25, down 0.94% on the day, with a bearish technical signal from moving averages. The company reported $62.58B in 2025 revenue and a net income margin of 11.83%, with recent quarterly earnings consistently beating expectations. A dividend of $0.43 per share is scheduled for payment on September 1, 2026. The stock's valuation includes a P/E of 18.51 and P/S of 2.19, while analyst consensus price target is $28.25.
Pfizer presents a mixed outlook with stable profitability and a strong dividend, but faces headwinds from patent expirations and competitive pressures. The stock offers value at current levels relative to analyst targets, though technical weakness and revenue declines from peak COVID-era sales pose near-term risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
